首页|颅内动脉瘤术后患者血清VEGFs、MMPs表达水平特征及对预后的预测效能

颅内动脉瘤术后患者血清VEGFs、MMPs表达水平特征及对预后的预测效能

Characteristics of VEGFs and MMPs levels in postoperative patients with intracranial aneurysm and their prognostic efficacy

扫码查看
目的 探讨颅内动脉瘤术后患者血清血管内皮生长因子(VEGFs)、基质金属蛋白酶(MMPs)水平特征及对预后的预测效能.方法 选取2021年12月—2023年12月就诊于新疆维吾尔自治区人民医院神经外科的颅内动脉瘤术后患者121例作为研究对象,根据术后1个月预后情况将患者分为预后良好组(n=92)和预后不良组(n=29).采用化学发光免疫测定法检测2组患者血清VEGFs、MMPs表达谱水平;Spearman相关性分析血清VEGFs、MMPs水平与颅内动脉瘤术后患者预后不良的相关性;Logistic回归分析颅内动脉瘤术后患者预后不良的危险因素;绘制受试者工作特征(ROC)曲线分析血清VEGFs、MMPs水平预测颅内动脉瘤术后患者预后不良的价值.结果 预后不良组患者血清VEGF-1、VEGF-2、MMP-1、MMP-2、MMP-9水平均显著高于预后良好组患者(t/P=4.455/<0.001、3.982/<0.001、4.848/<0.001、5.702/<0.001、5.144/<0.001);血清 VEGF-1、VEGF-2、MMP-1、MMP-2、MMP-9 水平均与颅内动脉瘤术后患者预后不良呈显著正相关(r/P=0.338/<0.001、0.361/<0.001、0.383/<0.001、0.386/<0.001、0.331/<0.001);血清VEGF-1、VEGF-2、MMP-1、MMP-2、MMP-9水平升高均是颅内动脉瘤术后患者预后不良的独立危险因素[OR(95%CI)=1.142(1.011~1.372)、1.126(1.004~1.276)、1.027(1.002~1.052)、1.029(1.006~1.052)、1.026(1.006~1.047)];血清 VEGF-1、VEGF-2、MMP-1、MMP-2、MMP-9 水平独立及联合预测颅内动脉瘤术后患者预后不良的AUC分别为0.729、0.744、0.759、0.761、0.724、0.890,联合预测的效能大于各指标独立预测效能(Z/P=4.344/<0.001、4.185/<0.001、4.013/<0.001、4.010/<0.001、4.350/<0.001).结论 颅内动脉瘤术后患者血清VEGFs、MMPs表达水平与预后不良具有密切相关性.基于上述指标的联合预测模型对颅内动脉瘤术后患者不良预后有较高预测价值.
Objective To investigate the features of vascular endothelial growth factor(VEGFs)and matrix metallo-proteinase(MMPs)concentrations in postoperative individuals with intracranial aneurysms and their prognostic predictive value.Methods During the period from December 2021 to December 2023,a total of 121 patients diagnosed with intracrani-al aneurysms were enrolled in our hospital and categorized into either the favorable prognosis group(n=92)or the unfavor-able prognosis group(n=29).Comparative analyses were conducted to explore the distinctions in general clinical character-istics as well as the levels of serum VEGFs and MMPs expressions between these two groups.The study utilized Spearman correlation test and binary Logistic regression analysis to discover the potential risk factors linked to unfavorable postopera-tive results in individuals diagnosed with intracranial aneurysms.Moreover,the effectiveness of these risk factors in predic-ting the probability of an unfavorable postoperative outcome was evaluated through the receiver operating characteristic(ROC)curve analysis.Results The average serum levels of VEGF-1,VEGF-2,MMP-1,MMP-2,and MMP-9 were also sig-nificantly elevated in the poor prognosis group compared to the good prognosis group(t/P=4.455/<0.001,3.982/<0.001,4.848/<0.001,5.702/<0.001,5.144/<0.001).Spearman correlation analysis revealed a positive correlation between age,diabe-tes mellitus,and serum levels of VEGF-1,VEGF-2,MMP-1,MMP-2,and MMP-9 with poor prognosis among postoperative patients with intracranial aneurysms(r/P=0338/<0.001,0361/<0.001,0383/<0.001,0386/<0.001,0331/<0.001).Addition-ally,multivariate Logistic regression analysis indicated that serum VEGF-1,VEGF-2,MMP-1,MMP-2,and MMP-9 were iden-tified as pivotal risk factors for poor prognosis in patients with intracranial aneurysms post operation[OR(95% CI)=1.142(1.011-1.372),1.126(1.004-1276),1.027(1.002-1.052),1.029(1.006-1.052),1.026(1.006-1.047)].The AUC values for ser-um VEGF-1,VEGF-2,MMP-1,MMP-2,MMP-9 levels independently predicting poor prognosis in patients after intracranial aneurysm surgery were 0.729,0.744,0.759,0.761,and 0.724 respectively,with a combined prediction AUC of 0.890.The effica-cy of the combined prediction was greater than that of each individual marker(Z/P=4.344/<0.001,4.185/<0.001,4.013/<0.001,4.010/<0.001,4.350/<0.001).Conclusion The correlation between serum VEGFs and MMPs expression levels in postoperative intracranial aneurysm patients and poor prognosis is significant.Developing a predictive model incorporating these markers holds clinical importance in early assessment and prompt intervention for this patient population,ultimately enhancing outcomes.Furthermore,such a model represents a promising biological target for future therapeutic strategies.

Intracranial aneurysmVascular endothelial growth factorMatrix metalloproteinasePrognosis

克力斯坦·夏依扎提、王乐、如克亚·白克力

展开 >

830000 乌鲁木齐,新疆维吾尔自治区人民医院神经外科

颅内动脉瘤 血管内皮生长因子 基质金属蛋白酶 预后

新疆维吾尔自治区自然科学基金项目

2021D01C428

2024

疑难病杂志
中国医师协会

疑难病杂志

CSTPCD
影响因子:1.171
ISSN:1671-6450
年,卷(期):2024.23(9)